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Systematic Review
should be undertaken only by expert arachnologist
morphological and distributional attributes.1,2
As bites that cause only minor effects are rarely
correctly attributed to expertly identified spiders, it ha
to determine the rate of severe envenoming for differe
example, the suspected envenoming rate of the Sydn
spider (Atrax robustus) is 10%–25%,3-6 but this may bMJA • Volume 182 NumABSTRACT
Objective:  To investigate species-specific envenoming rates 
and spectrum of severity of funnel-web spider bites, and the 
efficacy and adverse effects of funnel-web spider antivenom.
Data sources:  Cases were identified from a prospective study 
of spider bite presenting to four major hospitals and three state 
poisons information centres (1999–2003); museum records of 
spider specimens since 1926; NSW Poisons Information Centre 
database; MEDLINE and EMBASE search; clinical toxinology 
textbooks; the media; and the manufacturer’s reports of 
antivenom use.
Data extraction:  Patient age and sex, geographical location, 
month, expert identification of the spider, clinical effects and 
management; envenoming was classified as severe, mild–
moderate or minor/local effects.
Data synthesis:  198 potential funnel-web spider bites were 
identified: 138 were definite (spider expertly identified to 
species or genus), and 77 produced severe envenoming. All 
species-identified severe cases were attributed to one of six 
species restricted to NSW and southern Queensland. Rates 
of severe envenoming were: Hadronyche cerberea (75%), 
H. formidabilis (63%), Atrax robustus (17%), Hadronyche sp. 
14 (17%), H. infensa (14%) and H. versuta (11%). Antivenom was 
used in 75 patients, including 22 children (median dose, 
3 ampoules; range, 1–17), with a complete response in 97% 
of expertly identified cases. Three adverse reactions were 
reported, all in adults: two early allergic reactions (one mild 
and one with severe systemic effects requiring adrenaline), 
and one case of serum sickness.
Conclusions:  Severe funnel-web spider envenoming is 
confined to NSW and southern Queensland; tree-dwelling 
funnel webs (H. cerberea and H. formidabilis) have the highest 
envenoming rates. Funnel-web spider antivenom appears 
MJA 2005; 182: 407–411
effective and safe; severe allergic reactions are uncommon.un
wo
AuF nel-web spiders are the most dangerous spiders in therld and continue to cause severe envenoming in easternstralia. They belong to the family Hexathelidae: Atracinae
and comprise about 40 species in two genera (Atrax and Hadrony-
che). Although some species are well known, many have not been
formally characterised, and species identification can be difficult. It
s, using both
 published or
s been difficult
nt species. For
ey funnel-web
e confounded
by the inclusion of trapdoor-spider bites as non-envenoming bites
(as trapdoor spiders are often misidentified as funnel-web spiders6),
and by publication bias of more severe cases.
Funnel-web spider antivenom was first used in 1981. It is
produced against A. robustus venom and, based on case reports and
small case series, appears effective for severe envenoming.4,5,7
Although it is assumed to have few adverse effects, there are no large
studies of its safety.
Our study was undertaken to:
• investigate the envenoming rate and spectrum of severity of
different funnel-web spider species; and
• investigate systematically the use of funnel-web spider
antivenom, including dose, efficacy in envenoming by different
species, and adverse reactions.
METHODS
Data sources
We attempted to identify all known cases of funnel-web spider bite
using multiple sources. These included a prospective study of
patients with spider bite presenting to the Royal Prince Alfred
Hospital, Sydney (NSW) or Royal Darwin Hospital (Northern
Territory) (February 1999 to April 2003), or to hospitals served by
the Hunter Region Toxicology Service (NSW) (July 2000 to April
2003), as well as people with spider bite contacting the New Southber 8 • 18 April 2005 407
SYSTEMATIC  REVIEWWales, Queensland or Western Australian Poisons Information
Centres (February 1999 to April 2003).6,8 All people who provided
the spider for expert identification were eligible for the study.
Major museums in areas where funnel-web spiders occur were
contacted to find specimens responsible for bites, comprising the
Australian Museum (1926–2004), Museum Victoria (1980–2004),
Queensland Museum (1968–2004), South Australian Museum
(1985–2004), Tasmanian Museum (1972–2004), and the Queen
Victoria Museum in Launceston (1994–2004). We also contacted
arachnologists working outside museums.
We also undertook a systematic review of scientific publications.
MEDLINE, OLD MEDLINE (1951–1965) and EMBASE were
searched to 14 May 2004 using the terms “Atrax”, “Hadronyche”,
“Atracinae”, “Hexathelidae”, “Dipluridae” and “funnel-web spider”.
The reference lists of resulting publications were also searched, and
authors were contacted where possible.
In addition, we searched:
• Reports of antivenom use to the manufacturer, CSL Limited, for
the period 1994–2003 (earlier reports were published
previously4,9);
• The database of the NSW Poisons Information Centre for funnel-
web spider bites referred to a consultant toxicologist from January
1997 (when a searchable electronic database came into operation) to
June 2004 (this database codes funnel-web spider bites only if the
diagnosis is clear, and thus is biased to envenoming);
• The database of the Hunter Area Toxicology Service, Newcastle,
NSW, for the period 1987 to June 2004;
• Internet sites of major media organisations — the f2 Network
(Fairfax Publications) and newstext.com.au (News Corporation)
— for the period 1984 to June 2004;
• The Internet using the search engine Google and search term
“funnel-web spider bite” to 17 May 2004; and
• Major Australian and international clinical toxinology textbooks.
We also contacted clinical toxicologists appointed to the NSW
and Queensland Poisons Information Centres to identify any other
unreported bites, envenomings or antivenom uses and to obtain
further clinical details of patients they had treated. Clinicians
involved in treating patients identified from other sources were also
contacted for further information. Cases identified in an ongoing
prospective study of funnel-web spider envenoming conducted by
the authors, any other cases known to the authors, and cases
managed in their hospitals were also included.
Many cases were identified from multiple sources. Date and
location of the bite and patient age and sex were compared to avoid
duplicating cases.
Data extraction
For all reports of bites and cases where antivenom was used, the
following information was extracted, if available: patient age and
sex, geographical location, date, whether the spider was collected
and identified by an expert arachnologist, species of spider, circum-
stances and anatomical site of the bite, local and systemic effects,
and management (hospital attendance, length of stay and antivenom
use, including efficacy and adverse effects).
Data analysis
Envenoming rate
We determined the rate of severe envenoming for bites by expertly
species-identified spiders obtained from the prospective study6 or
museum records, as these sources collected consecutive cases. Bites
identified from published reports were excluded because of bias to
publication of severe envenoming cases, as were individual reports
not part of a consecutive series.
Envenoming was classified as:
• severe, if three or more features of systemic funnel-web spider
envenoming were present (from at least two groups), as defined by:
–  autonomic effects (diaphoresis, salivation, lacrimation, piloerec-
tion, miosis, mydriasis);
– cardiovascular effects (hypertension, hypotension, tachycardia,
bradycardia);
– neurological effects (oral paraesthesia, muscle fasciculations,
muscle spasm); or
– pulmonary oedema.
• mild to moderate, if there were less than three defined features of
funnel-web spider envenoming; or regional neurotoxic effects only;
or
• minor or local effects only.6
Although general systemic effects such as vomiting, headache and
abdominal pain are common in funnel-web spider bites, they are not
sufficiently specific to be included in the definition.
Features of severe envenoming
To determine the time to onset of severe envenoming and frequency
of specific clinical effects, we analysed all cases in which a large black
spider was seen in the act of biting, and the patient had three or
more features of systemic funnel-web spider envenoming, even
when the spider was not expertly identified.
Antivenom use
All cases in which the patient received funnel-web spider antivenom
were analysed to determine antivenom safety and efficacy. These
included cases which were unlikely to be funnel-web spider bites.
Statistical analysis
All analyses were performed using StatsDirect10 and StatXact11
computer software. Envenoming rates were compared between
species using the Fisher–Freeman–Halton exact test. For descriptive
statistics, median and interquartile range (IQR) were used for non-
normally distributed data.
RESULTS
We identified 198 cases which were either potential funnel-web
spider bites or cases where funnel-web spider antivenom was used:
• 138 cases where the spider was expertly identified, 130 to species
level (eight specimens were too immature for species identification);
these included 29 cases where antivenom was given;
• 46 cases where antivenom was given on the clinical suspicion of
funnel-web spider envenoming, with or without an observed bite by
a black spider; these included nine cases which were definitely or
probably not funnel-web spider bites (three definite bites by another
species [Namea brisbanensis, Missulena bradleyi, Misgolas sp.], one
suspected redback spider bite, one bite by another unidentified
spider, and four with no history of a bite and unusual clinical
features); and
• 14 cases which had the classical features of severe funnel-web
spider envenoming but occurred before 1981 (when antivenom
became available), and no spider was identified.
The primary sources of the 198 bite reports were:
• 16 from the previously published prospective study;6408 MJA • Volume 182 Number 8 • 18 April 2005
SYSTEMATIC  REVIEW• 89 from records of specimens at the Australian Museum (64),
Queensland Museum (16), Tasmanian Museum (8) and Museum
Victoria (1);
• 43 from the MEDLINE and EMBASE searches (13 case reports
and series3,4,6-8,12-19 in 185 publications) and from reference lists
and textbooks (a further 12 reports5,20-29).
• 50 from other sources: CSL antivenom reports (14), NSW
Poisons Information Centre (9); the media (6); Hunter Area Toxicol-
ogy Service (5); ongoing national prospective study of snake and
spider envenoming (3) and other reports from authors (13).
Species-specific rates of envenoming
The species responsible and severity of envenoming for the 138
expertly identified funnel-web spider bites are shown in Box 1.
There were 43 cases of severe envenoming, attributed to six species
— the southern tree (Hadronyche cerberea), northern tree (H.
formidabilis), Sydney (Atrax robustus), Port Macquarie (Hadronyche
sp. 14), Toowoomba or Darling Downs (H. infensa), and Blue
Mountains (H. versuta) funnel-web spiders. Rates of severe enven-
oming by these species are shown in Box 2. Rates varied significantly
(P = 0.02; Fisher–Freeman–Halton exact), from 11% for the Blue
Mountains funnel-web spider to 75% for the southern tree funnel-
web spider.
Female spiders were responsible for 17 of the 138 expertly
identified bites: A. robustus (7), H. infensa (5), H. versuta (2), H.
modesta (1), Hadronyche sp. 14 (1) and unknown Hadronyche sp.
(immature speciment) (1). Effects were local in 14 cases, and mild
envenoming in three (all H. infensa).
Bites in which the spider was expertly identified as a funnel-web
spider occurred in all eastern states and territories: NSW (108),
Australian Capital Territory (1), Queensland (16), Victoria (3),
Tasmania (9), and South Australia (1). However, cases of severe
envenoming were confined to NSW and southern Queensland.
Features of severe envenoming
A total of 77 cases were classified as severe funnel-web spider
envenoming: 43 expertly identified cases, and another 34 in which a
large black spider was seen biting but was not expertly identified,
and the patient had three or more features of severe funnel-web
envenoming. Thirty-two of these 77 cases (42%) were in children.
The median number of cases of severe envenoming for 1981–2004
was 2 per year (IQR, 1–3; range, 0–7). Most cases occurred between
November and March.
The 77 cases comprised:
• 13 deaths (all before the introduction of antivenom in 1981),
seven in children;
• 16 non-fatal bites before antivenom introduction (10 with spe-
cies identification and 6 with non-expert identification of a Sydney
funnel-web spider); and
• 48 cases treated with antivenom.
Detailed information on clinical effects was available for 59 cases
(Box 3). Time to onset of symptoms was known for 42 cases of
severe envenoming and ranged from 8 to 175 minutes (median, 28
min; IQR, 15–45 min). Two patients had onset after 2 hours; both
had a pressure immobilisation bandage applied, and in one of these,
symptoms occurred on release of the bandage.14 The use of pressure
immobilisation bandages was recorded in 44% of cases since it was
first recommended in 1980.30
Antivenom safety and efficacy
Antivenom was given to 75 patients, including 29 with expertly
identified funnel-web spider bites, and nine who definitely or
1 Severity of envenoming in 138 expertly identified funnel-web spider bites reported in different sources 
Common 
funnel-web 
name
Museum records Prospective study6 Other* All bites
Species†
Minor/
local 
Mild/
moderate Severe
Minor/
local
Mild/
moderate Severe
Minor/
local
Mild/
moderate Severe
Minor/
local
Mild/
moderate Severe Total
Atrax robustus Sydney 16 0 3 3 0 1 1 1 18 20 1 22 43
Hadronyche infensa Toowoomba 5 5 2 1 1 0 0 0 1 6 6 3 15
H. versuta Blue Mountains 8 0 1 0 0 0 1 0 1 9 0 2 11
H. formidabilis Northern tree 2 1 5 0 0 0 0 0 2 2 1 7 10
H. venenata Tasmanian 8 0 0 0 1 0 0 0 0 8 1 0 9
H. cerberea Southern tree 1 0 2 0 0 1 0 0 4 1 0 7 8
Hadronyche sp. 14‡ Port Macquarie 1 0 1 3 1 0 0 1 1 4 2 2 8
Hadronyche sp. 7 Bermagui 3 2 0 1 0 0 0 0 0 4 2 0 6
Hadronyche sp. 20 Illawarra 1 0 0 0 0 0 4 0 0 5 0 0 5
Hadronyche sp. 11 Hunter Region 2 0 0 0 1 0 0 0 0 2 1 0 3
Other species§ 7 3 0 0 0 0 2 0 0 9 3 0 12
Immature¶ 6 0 0 2 0 0 0 0 0 8 0 0 8
Total 62 13 14 10 4 2 4 2 27 76 19 43 138
* Other sources comprised scientific publications (27), NSW Poisons Information Centre database (2), referrals to author M M F (2), newspaper reports (1), and ongoing 
prospective study of snake and spider envenoming (1). † All belong to the genera Atrax or Hadronyche. 
‡ Hadronyche species 14 and 15 were combined because of their taxonomic similarities. 
§ Other species were Atrax sp. 1 (Bega funnel-web: one case with local effects, one mild–moderate effects), Atrax sp. 2 (Batlow funnel-web: one local, one mild–
moderate effects), H. modesta (two local effects), Hadronyche sp. 9 (Gippsland funnel web; one mild–moderate effects), H. adelaidensis, H. valida, Hadronyche sp. 
2 (Alpine funnel web), Hadronyche sp. 3 (South-west slopes funnel web), Hadronyche sp. 4 (Monaro funnel web) (each with one case with local effects). 
¶ Although definitely identified as members of the Hexathelidae: Atracinae, eight spiders were too immature to be identified to species level. MJA • Volume 182 Number 8 • 18 April 2005 409
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included 6 infants, 22 children aged 2–15 years, two pregnant
women and two women who were breastfeeding. The median dose
of antivenom was three ampoules (IQR, 2–5; range, 1–17).
Adverse effects were seen in three of the 75 patients, all adults:
• a severe systemic reaction with hypotension which occurred
1 hour after administration of four ampoules of antivenom and
responded to subcutaneous adrenaline; the patient was given
two more ampoules of antivenom for ongoing envenoming
without further adverse effects;
• itchiness and throat tightness occurring within hours of adminis-
tration of three ampoules of antivenom which responded to pro-
methazine and salbutamol; and
• serum sickness presenting 7 days after administration of five
ampoules of antivenom.20
There were no adverse effects in infants, children or pregnant
women administered antivenom. The rate of severe allergic reactions
was therefore 1 in 75 (1.3%; 95% CI, 0–7%).
Among the nine patients who had no evidence of a funnel-web
spider bite but received antivenom, one died. This patient’s condi-
tion initially appeared to respond to antivenom, but had no history
of spider bite, and no spider was found.
A complete response to the antivenom was reported in 28 of 29
patients (97%) with expertly identified funnel-web spider bites and
information on antivenom response. Complete responses to
antivenom were seen in patients bitten by the six funnel-web species
that caused severe envenoming and by one patient bitten by
Hadronyche sp. 7, which caused moderate envenoming.4
The median hospital stay among patients who survived severe
envenoming was 1.8 days for those treated with antivenom (95% CI,
1.3–3.7 days) versus 3.5 days for those who were not treated with
antivenom (95% CI, 2.6–9.4 days; P =0.02 by Mann–Whitney test).
DISCUSSION
This study has better defined the range of the most dangerous
funnel-web spider species and their envenoming rates. We found
that species which caused severe envenoming were restricted to
NSW and southern Queensland. The study also identified 75
patients who received funnel-web spider antivenom, with a rate of
severe adverse effects less than 2%, and complete responses in more
than 90% of those with expertly identified funnel-web spider bites,
including patients bitten by the six most dangerous species.
We found apparent differences in envenoming rates between
species: the Sydney funnel web spider had a rate of severe envenom-
ing of 17%, while the southern and northern tree funnel web spiders
had much higher rates (over half of cases). These findings are not
consistent with results of in vitro venom studies, which suggested
similar toxicity for venom of 10 Atrax and Hadronyche species,
including some not found to cause envenoming in our study.31 The
latter may be due to the limited number of bites by these spiders.
Alternatively, the difference in envenoming rates may be due to
differences in spider size, fang length, behaviour and ability to inject
venom, rather than in venom toxicity. Determination of the enven-
oming rate is limited by the small number of cases and differences in
the data sources. Ideally, a large prospective multicentre study would
provide more accurate rates.
Severe envenoming was not reported for female funnel-web
spiders, consistent with previous findings that most female funnel-
web spiders have less potent venom than male spiders. However,
there were no reported bites by female tree funnel-web spiders,
which have been shown in vitro to be highly venomous.31
Antivenom was effective in people bitten by all six dangerous
species, consistent with results of in vitro antivenom studies.31
The onset of severe envenoming is rapid, with deaths reported
within an hour.29 In our study, the median time to onset of
envenoming was 28 minutes, with only two cases having onset after
2 hours, both with a pressure immobilisation bandage or tourniquet
applied. This suggests that patients are highly unlikely to develop
3 Frequency of clinical effects (95% CI) in severe cases of 
funnel-web spider envenoming where comprehensive 
information was available
Clinical effect
Adults
(n = 36)
Children
(n = 23)
Total 
(n = 59)
Autonomic
Diaphoresis 83% (67%–94%) 70% (47%–87%) 78%
Increased salivation 44% (28%–62) 43% (23%–66%) 44%
Piloerection 25% (12%–42) 39% (20%–61%) 31%
Lacrimation 17% (6%–33%) 4% (0–22%) 12%
Pupillary changes 36% (21%–54%) 26% (10%–48%) 32%
General systemic
Agitation 44% (28%–62%) 52% (31%–73%) 47%
Vomiting 33% (19%–51%) 52% (31%–73%) 41%
Headache 14% (5%–29%) 4% (0–22%) 10%
Abdominal pain 8% (2%–23%) 13% (3%–34%) 10%
Cardiovascular
Hypertension 81% (64%–92%) 65% (43%–84%) 75%
Hypotension 14% (5%–29%) 4% (0–22%) 10%
Tachycardia 53% (36%–70%) 70% (47%–87%) 59%
Bradycardia 11% (3%–26%) 9% (1%–28%) 10%
Neurological
Oral paraesthesia 44% (28%–62%) 13% (3%–34%) 32%
Fasciculations 67% (49%–81%) 35% (16%–57%) 54%
Muscle spasm 19% (8%–36%) 13% (3%–34%) 17%
Coma/unconsciousness 0% (0–10%) 22% (7%–44%) 8%
Pulmonary oedema 44% (28%–62%) 70% (47%–87%) 54%
2 Rate of severe envenoming for the six most medically 
important species of funnel-web spider
Common name
No. of bites* Severe
envenoming
rate (95% CI)Species Severe Total
H. cerberea Southern tree 3 4 75% (19%–99%)
H. formidabilis Northern tree 5 8 63% (24%–91%)
Atrax robustus Sydney 4 23 17% (5%–39%)
Hadronyche sp. 14 Port Macquarie 1 6 17% (0–64%)
H. infensa Toowoomba 2 14 14% (2%–43%)
H. versuta Blue Mountains 1 9 11% (0–48%)
* Expertly identified bites identified from the prospective study or museum 
records; other sources were excluded because of the potential for bias to 
severe cases.410 MJA • Volume 182 Number 8 • 18 April 2005
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tive studies, it is important to observe patients with suspected
funnel-web spider bites for 4 hours.
The rarity of severe funnel-web spider envenoming (a median of
two cases annually in the past 10 years, when data collection was
most complete) has made it difficult to evaluate the efficacy and
safety of funnel-web antivenom. Sutherland suggested in 1992 that
about 50 patients had been treated with antivenom in the first
decade of its availability,9 with nine in the first 3 years.4 We report
use of antivenom in 75 patients over 23 years, including infants,
children, and pregnant and breast-feeding women, with only one
severe immediate allergic reaction and one delayed reaction (serum
sickness) (< 2% for each), both in adults. Although the study may
have underestimated the rate of delayed reactions, it is unlikely to
have underestimated early reactions.
We found no confirmed deaths after funnel-web spider bite since
the antivenom was introduced. Antivenom completely reversed the
effects of clinical envenoming in 97% of expertly identified cases.
This confirms previous clinical reports12,13,15 and results of animal
research31 suggesting that the antivenom, which is produced against
A. robustus venom, is effective against Hadronyche spp. We also
found that use of funnel-web spider antivenom appeared to reduce
length of hospital stay after envenoming, consistent with the finding
of a previous prospective study in a single hospital.5 This supports
the continuing use of funnel-web spider antivenom as the mainstay
of treatment for severe funnel-web spider envenoming, despite the
lack of a controlled trial.
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